Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SCHWAB CHARLES CORPSCH · Entity 1218 | Executive Vice President | February 25, 2004 | February 26, 2004 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SCHWAB CHARLES CORP
Report date February 25, 2004 · Filed February 26, 2004
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 268,882 |
Reported balance
After 2004-02-25 transaction · row 1
1 source rowRow 1 · 2004-02-25 · Sale · Disposed 20,627 · Balance 268,882 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2004. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2004.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PFIZER INC
Report date December 15, 2010 · Filed December 17, 2010
Section 16 reporting ended · disclosed 2010-12-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock Units SSPSEC Table II · derivative / convertible security | Direct | 1,605 |
Reported balance
After 2010-12-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2010-12-15 · Grant · Acquired 80 · Balance 1,605 F1: Each unit represents one phantom share of common stock. F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit represents one phantom share of common stock.
F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2010 Filed Dec 17, 2010 20:41 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 80 | $17.08 | $1,366.40 |
DisclosureSEC source: 0001225208-10-027358 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Former Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,605 Underlying: Common Stock · 80 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 30, 2010 Filed Dec 2, 2010 00:11 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 82 | $16.30 | $1,336.60 |
DisclosureSEC source: 0001225208-10-026042 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,525 Underlying: Common Stock · 82 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 15, 2010 Filed Nov 16, 2010 23:34 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 98 | $16.75 | $1,641.50 |
DisclosureSEC source: 0001225208-10-025020 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,443 Underlying: Common Stock · 98 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| November 03, 2010 Filed Nov 3, 2010 19:12 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 1,263 | $17.52 | $22,127.76 |
DisclosureSEC source: 0001225208-10-024131 · doc4.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,833 Read SEC document |
| October 29, 2010 Filed Nov 1, 2010 20:12 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 77 | $17.42 | $1,341.34 |
DisclosureSEC source: 0001225208-10-023819 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,345 Underlying: Common Stock · 77 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| October 15, 2010 Filed Oct 18, 2010 22:56 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 76 | $17.75 | $1,349.00 |
DisclosureSEC source: 0001225208-10-023189 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,268 Underlying: Common Stock · 76 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 30, 2010 Filed Oct 1, 2010 19:24 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 79 | $17.17 | $1,356.43 |
DisclosureSEC source: 0001225208-10-021675 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,192 Underlying: Common Stock · 79 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| September 28, 2010 Filed Sep 29, 2010 20:55 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,087 | $17.43 | $18,946.41 |
DisclosureSEC source: 0001225208-10-021532 · doc4.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,096 F1 · kind: Represents withholding of shares to satisfy tax obligations upon vesting of restricted stock units. Read SEC document |
| September 15, 2010 Filed Sep 17, 2010 12:29 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 77 | $17.27 | $1,329.79 |
DisclosureSEC source: 0001225208-10-020984 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,113 Underlying: Common Stock · 77 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 31, 2010 Filed Sep 2, 2010 11:59 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 87 | $15.91 | $1,384.17 |
DisclosureSEC source: 0001225208-10-020180 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,036 Underlying: Common Stock · 87 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F1 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F1 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 31, 2010 Filed Sep 2, 2010 12:02 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 87 | $15.91 | $1,384.17 |
DisclosureSEC source: 0001225208-10-020182 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,036 Underlying: Common Stock · 87 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F1 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F1 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| August 13, 2010 Filed Aug 17, 2010 15:20 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 94 | $16.08 | $1,511.52 |
DisclosureSEC source: 0001225208-10-019325 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 949 Underlying: Common Stock · 94 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 30, 2010 Filed Aug 3, 2010 15:19 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 90 | $15.00 | $1,350.00 |
DisclosureSEC source: 0001225208-10-018084 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 855 Underlying: Common Stock · 90 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| July 15, 2010 Filed Jul 16, 2010 20:51 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 92 | $14.87 | $1,368.04 |
DisclosureSEC source: 0001225208-10-017303 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 765 Underlying: Common Stock · 92 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 30, 2010 Filed Jul 1, 2010 20:53 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 95 | $14.26 | $1,354.70 |
DisclosureSEC source: 0001225208-10-016174 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 673 Underlying: Common Stock · 95 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| June 15, 2010 Filed Jun 16, 2010 19:05 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 88 | $15.52 | $1,365.76 |
DisclosureSEC source: 0001225208-10-015308 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 578 Underlying: Common Stock · 88 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 28, 2010 Filed Jun 1, 2010 21:51 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 89 | $15.23 | $1,355.47 |
DisclosureSEC source: 0001225208-10-014345 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490 Underlying: Common Stock · 89 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| May 27, 2010 Filed May 27, 2010 19:56 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 13,520 | $15.35 | $207,532.00 |
DisclosureSEC source: 0001225208-10-014121 · doc4.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,832 Read SEC document |
| May 14, 2010 Filed May 18, 2010 19:55 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 88 | $16.20 | $1,425.60 |
DisclosureSEC source: 0001225208-10-013286 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 401 Underlying: Common Stock · 88 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2010 Filed May 3, 2010 19:43 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 81 | $16.72 | $1,354.32 |
DisclosureSEC source: 0001225208-10-011625 · doc4.xml · derivative · entry 3 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313 Underlying: Common Stock · 81 shares Expires not disclosed F2 · derivative.exercise_price: Each unit represents one phantom share of common stock. F3 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F3 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| April 30, 2010 Filed May 3, 2010 19:43 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 9,999 | $16.72 | $167,183.28 |
DisclosureSEC source: 0001225208-10-011625 · doc4.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,035 F1 · kind: Represents withholding of shares to satisfy tax obligations upon vesting of restricted stock units. Read SEC document |
| April 15, 2010 Filed Apr 16, 2010 21:34 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 80 | $16.99 | $1,359.20 |
DisclosureSEC source: 0001225208-10-010497 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232 Underlying: Common Stock · 80 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 31, 2010 Filed Apr 1, 2010 22:40 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 76 | $17.15 | $1,303.40 |
DisclosureSEC source: 0001225208-10-009467 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152 Underlying: Common Stock · 76 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| March 15, 2010 Filed Mar 17, 2010 13:25 UTC | PFIZER INC PFE · Entity 2863 | GrantPhantom Stock Units SSP · Derivative | 76 | $17.26 | $1,311.76 |
DisclosureSEC source: 0001225208-10-008384 · doc4.xml · derivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76 Underlying: Common Stock · 76 shares Expires not disclosed F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 78,829 | $0.00 Strike: $17.69 | $0.00 |
DisclosureSEC source: 0001225208-10-006392 · doc4.xml · derivative · entry 3 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,829 Underlying: Common Stock · 78,829 shares Expires 2015-02-25 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2010 Filed Mar 2, 2010 02:01 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 32,591 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-10-006392 · doc4.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,034 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements. Read SEC document |
| October 30, 2009 Filed Nov 3, 2009 21:37 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 32,751 | $0.00 Strike: $17.03 | $0.00 |
DisclosureSEC source: 0001225208-09-021513 · doc4.xml · derivative · entry 2 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,751 Underlying: Common Stock · 32,751 shares Expires 2014-10-30 F2 · derivative.exercise_date: The stock appreciation rights will vest on the third anniversary of the date of grant, provided that the reporting person remains in the continuous employ of Pfizer until that anniversary date, and will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights will vest on the third anniversary of the date of grant, provided that the reporting person remains in the continuous employ of Pfizer until that anniversary date, and will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| October 30, 2009 Filed Nov 3, 2009 21:37 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 8,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-09-021513 · doc4.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,307 F1 · shares: The reported transaction constitutes the grant of restricted stock units, which will vest and be settled in shares of Pfizer common stock on the third anniversary of the date of grant, provided that the reporting person remains in the continuous employ of Pfizer until that anniversary date. Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:27 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 83,955 | $0.00 Strike: $12.70 | $0.00 |
DisclosureSEC source: 0000078003-09-000034 · mcl1971.xml · derivative · entry 2 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,955 Underlying: Common Stock · 83,955 shares Expires 2014-02-26 F2 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F2 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 26, 2009 Filed Mar 2, 2009 23:27 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 50,019 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-09-000034 · mcl1971.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,408 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 88,810 | $0.00 Strike: $22.55 | $0.00 |
DisclosureSEC source: 0000078003-08-000030 · mcl1682.xml · derivative · entry 2 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,810 Underlying: Common Stock · 88,810 shares Expires 2013-02-28 F2 · derivative.exercise_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant F2 · derivative.expiration_date: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant Read SEC document |
| February 28, 2008 Filed Mar 4, 2008 01:04 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 21,949 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-08-000030 · mcl1682.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,018 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| September 28, 2007 Filed Oct 2, 2007 19:16 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000268 · mcl1605.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,214 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| April 30, 2007 Filed May 1, 2007 20:51 UTC | PFIZER INC PFE · Entity 2863 | GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $26.46 | $0.00 |
DisclosureSEC source: 0000078003-07-000102 · mcl1500.xml · derivative · entry 2 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2017-04-29 Read SEC document |
| April 30, 2007 Filed May 1, 2007 20:51 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-07-000102 · mcl1500.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 F1 · shares: The reported transaction constitutes the grant of restricted stock units. Read SEC document |
| February 25, 2004 Filed Feb 26, 2004 18:36 UTC | SCHWAB CHARLES CORP SCH · Entity 1218 | SaleCommon Stock | 20,627 | $11.96 | $246,698.92 |
DisclosureSEC source: 0001209774-04-000001 · edgar.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,882 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2004. Read SEC document |
| October 30, 2003 Filed Nov 3, 2003 20:15 UTC | SCHWAB CHARLES CORP SCH · Entity 1218 | Exercise / conversionNon Qualified Stock Option (right to buy) · Derivative | 6,250 | $0.00 Strike: $10.47 | $0.00 |
DisclosureSEC source: 0001209774-03-000004 · edgar.xml · derivative · entry 3 MCLEOD MARY S · CIK 0001209774 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,022 Underlying: Common Stock · 6,250 shares Expires 2012-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2003 Filed Nov 3, 2003 20:15 UTC | SCHWAB CHARLES CORP SCH · Entity 1218 | SaleCommon Stock | 6,250 | $13.80 | $86,250.00 |
DisclosureSEC source: 0001209774-03-000004 · edgar.xml · nonDerivative · entry 2 MCLEOD MARY S · CIK 0001209774 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,509 Read SEC document |
| October 30, 2003 Filed Nov 3, 2003 20:15 UTC | SCHWAB CHARLES CORP SCH · Entity 1218 | Exercise / conversionCommon Stock | 6,250 | $10.47 | $65,437.50 |
DisclosureSEC source: 0001209774-03-000004 · edgar.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 22, 2003 Filed Jul 23, 2003 21:45 UTC | SCHWAB CHARLES CORP SCH · Entity 1218 | GrantCommon Stock | 182,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209777-03-000004 · edgar.xml · nonDerivative · entry 1 MCLEOD MARY S · CIK 0001209774 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,509 F1 · kind: The shares were granted under the Company's 1992 Stock Incentive Plan and/or 2001 Stock Incentive Plan and vest 25% on the third and fourth anniversary of the grant date and 50% on the fifth anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.